Alejandro Zamilpa Selected Research

Pityriasis

1/2013	Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.
6/2004	Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro Zamilpa Research Topics

Disease

14	Inflammation (Inflammations) 04/2022 - 04/2012
11	Edema (Dropsy) 07/2022 - 04/2012
6	Hypertension (High Blood Pressure) 01/2019 - 01/2007
5	Pain (Aches) 04/2022 - 12/2013
4	Neuroinflammatory Diseases 03/2021 - 10/2019
3	Type 2 Diabetes Mellitus (MODY) 09/2021 - 06/2016
3	Stomach Ulcer (Gastric Ulcer) 03/2021 - 12/2013
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2019 - 01/2010
3	Anxiety Disorders (Anxiety Disorder) 01/2019 - 07/2007
3	Body Weight (Weight, Body) 02/2017 - 01/2007
2	Osteoarthritis 04/2022 - 05/2013
2	Insulin Resistance 09/2021 - 01/2007
2	Arthritis (Polyarthritis) 05/2020 - 01/2020
2	Fever (Fevers) 10/2019 - 01/2010
2	Alzheimer Disease (Alzheimer's Disease) 07/2019 - 07/2015
2	Obesity 03/2019 - 10/2007
2	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 07/2018
2	Schizophrenia (Dementia Praecox) 01/2019 - 07/2018
2	Mental Disorders (Mental Disorder) 07/2018 - 01/2007
2	Vulvovaginal Candidiasis 06/2017 - 01/2013
2	Diabetic Foot 03/2015 - 10/2014
2	Ulcer 03/2015 - 10/2014
2	Wounds and Injuries (Trauma) 10/2014 - 05/2013
2	Pityriasis 01/2013 - 06/2004
2	Tinea Pedis (Athlete's Foot) 01/2013 - 05/2003
2	Infections 04/2009 - 05/2003
1	Hyperalgesia 04/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Metabolic Diseases (Metabolic Disease) 09/2021
1	Brain Injuries (Brain Injury) 03/2021
1	Parasitic Diseases (Parasitic Disease) 03/2021
1	Dermatomycoses 07/2020
1	Onychomycosis (Tinea Unguium) 07/2020
1	Rheumatoid Arthritis 01/2020
1	Conjunctivitis 10/2019
1	Cognitive Dysfunction 07/2019
1	Gliosis 07/2019
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2019
1	Memory Disorders (Memory Loss) 01/2019
1	Catalepsy 07/2018
1	Vascular Remodeling 06/2018

Drug/Important Bio-Agent (IBA)

7	CarrageenanIBA 07/2022 - 05/2013
5	ethyl acetateIBA 03/2021 - 10/2014
4	CytokinesIBA 07/2022 - 01/2019
4	Angiotensin IIIBA 01/2019 - 01/2014
4	Ketoconazole (Nizoral)FDA LinkGeneric 01/2013 - 05/2003
3	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2007
3	LipopolysaccharidesIBA 03/2021 - 01/2020
3	KaolinIBA 05/2020 - 05/2017
2	Methylene Chloride (Dichloromethane)IBA 04/2022 - 01/2020
2	TriterpenesIBA 09/2021 - 07/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021 - 01/2018
2	Insulin (Novolin)FDA Link 09/2021 - 01/2007
2	Ethanol (Ethyl Alcohol)IBA 03/2021 - 12/2013
2	Blood Glucose (Blood Sugar)IBA 07/2020 - 01/2007
2	Methotrexate (Mexate)FDA LinkGeneric 05/2020 - 05/2017
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 04/2019
2	AcetoneIBA 01/2020 - 01/2014
2	Methanol (Carbinol)IBA 01/2020 - 01/2014
2	PhytochemicalsIBA 07/2019 - 06/2018
2	Peptides (Polypeptides)IBA 07/2019 - 07/2015
2	DiureticsIBA 03/2019 - 01/2010
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 01/2014
2	galphimine BIBA 01/2019 - 09/2012
2	AntioxidantsIBA 05/2018 - 07/2015
2	Pharmaceutical PreparationsIBA 06/2016 - 10/2014
2	PolyphenolsIBA 07/2015 - 01/2007
2	Lorazepam (Ativan)FDA LinkGeneric 09/2012 - 07/2007
2	Anthocyanins (Anthocyanin)IBA 10/2007 - 01/2007
1	AnthelminticsIBA 03/2021
1	ProstaglandinsIBA 03/2021
1	cantalasaponin-1IBA 03/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021
1	EnzymesIBA 03/2021
1	AntidotesIBA 03/2020
1	PoisonsIBA 03/2020
1	lyonisideIBA 10/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2019
1	LipidsIBA 03/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2019
1	Malondialdehyde (Propanedial)IBA 01/2019
1	tilirosideIBA 01/2019
1	Rosmarinic AcidIBA 01/2019
1	Alprazolam (Xanax)FDA LinkGeneric 01/2019
1	Apomorphine FDA Link 01/2019
1	Oleanolic AcidIBA 01/2019
1	ScopoletinIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 07/2018
1	Haloperidol (Haldol)FDA LinkGeneric 07/2018
1	Ketamine FDA LinkGeneric 07/2018
1	Losartan (Cozaar)FDA LinkGeneric 06/2018
1	cinnamic acidIBA 06/2018
1	Myristic AcidsIBA 06/2018

Therapy/Procedure

18	Traditional Medicine (Folk Remedies) 04/2022 - 05/2003
1	Therapeutics 03/2021
1	Oral Administration 05/2020